Skip to main content
. Author manuscript; available in PMC: 2017 Apr 18.
Published in final edited form as: Liver Int. 2015 Aug 8;36(3):401–409. doi: 10.1111/liv.12917

Fig. 4.

Fig. 4

miRNA expression pattern in CLK and deduced PCA. miRNAs up regulated in K-STA vs. CLK (A) and down-regulated in K-STA vs. CLK (B) in internal validation using qPCR. PCA based on the expression of the miRNAs associated with CLK (C). Left panel, CLK vs. tolerant patients (L-TOL and K-TOL) (likelihood 84%). Centre, CLK vs. liver recipients (L-TOL and L-STA) (likelihood 85%). Right panel CLK vs. kidney recipients (K-TOL and K-STA) (likelihood 78%).